Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or Tennessee for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to Tennessee only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. Tennessee (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

Raza Hashmi (NPI 1700089521)

Field	Value
Entity Type	Individual
Organization	Raza Hashmi
Address	6799 Great Oaks Rd Ste 200
City	Memphis
State	TN
ZIP	38138
Taxonomy	Rheumatology Physician
NPI Enumerated	June 8, 2007

Payer Source	Total Paid
Medicare	$3.9M
Medicaid	$0

Key Findings

This provider is effectively single‑payer: reported lifetime Medicare revenue of $3.9M and no Medicaid billing on file, so Medicare accounts for the provider’s entire documented public‑payer activity. Analysts should treat this profile as Medicare‑centric when assessing market reach or contract risk.

Revenue is highly concentrated in a small set of biologic drug codes: the top 3 Medicare codes (J0717, J0129, J3262) account for 64.9% of total Medicare revenue, with J0717 at 33.1%, J0129 at 17.1%, and J3262 at 14.7%. This concentration signals that a few high‑cost injectable biologics drive most billings and margin exposure.

The CPT/HCPCS mix points to a rheumatology practice built around in‑office administration of injectable biologics and infusion services: high‑revenue drug codes J0717, J0129, and J3262 sit alongside administration/chemotherapy codes such as 96401, 96372, 96375, and 96413 and disease‑monitoring labs like 86235. Together these codes suggest on‑site drug delivery capability (infusion/IM/SC) plus routine laboratory monitoring rather than a purely consultative outpatient model.

For certain product codes this provider is a national outlier: J0717 ranks #4 of 848 nationally (100th percentile; extreme outlier), indicating exceptionally high utilization of certolizumab pegol compared with peers. J3262 also ranks well above peers at #38 of 618 (94th percentile; notably above typical national volume), reinforcing that multiple biologics are provided at an unusually large scale.

Visit and administration volumes are also atypically large: the office E/M code 99214 ranks #3363 of 479517 (99th percentile; extreme outlier), and the administration/infusion‑related codes 96401 and 96372 rank #15 of 3868 (100th percentile; extreme outlier) and #30 of 58224 (100th percentile; extreme outlier), respectively. These ranks indicate the provider generates unusually high throughput of established‑patient visits and drug administration encounters relative to national peers.

Beyond the top three biologics, the practice bills a range of other specialty injectables and biosimilars: J0897 (8.2% of Medicare revenue) ranks #378 of 10057 (96th percentile; notably above typical), J3111 (4.1%) ranks #334 of 970 (65th percentile; typical), and Q5104 (3.5%) ranks #27 of 178 (85th percentile; typical). This pattern shows breadth in biologic offerings while still concentrating most dollars in a few agents.

Laboratory and monitoring services are an identifiable ancillary revenue stream that aligns with rheumatology care: 86235 (ENA panel) contributes $64K and ranks #55 of 746 (93th percentile; typical), and other labs such as 83970, 82306, 82607, and 85025 appear on the top‑25 list. These tests support ongoing disease monitoring and safety surveillance for patients on immunomodulatory therapies.

The provider has long tenure in the NPI registry (enumerated 2007-06-08 (~19 years ago)), consistent with an established specialty practice capable of sustaining high volumes of biologic administration and related services. For payers and competitors, this combination of longevity plus concentrated biologic/infusion volume signals a mature, treatment‑focused rheumatology operation with potential implications for specialty drug procurement and site‑of‑care arrangements.

Medicare: Complete Services Breakdown

The CPT/HCPCS codes generating the most Medicare revenue for this provider.

75 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
J0717	Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)	321,200	$1	$1.3M
J0129	Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)	20,030	$30	$660.8K
J3262	Injection, tocilizumab, 1 mg	113,620	$10	$568.1K
J0897	Injection, denosumab, 1 mg	17,580	$20	$316.5K
J3111	Injection, romosozumab-aqqg, 1 mg	19,950	$10	$159.6K
Q5104	Injection, infliximab-abda, biosimilar, (renflexis), 10 mg	4,550	$30	$136.6K
99214	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the…	1,540	$90	$135.2K
J1602	Injection, golimumab, 1 mg, for intravenous use	12,750	$10	$127.5K
96401	The provider administers nonhormonal, antineoplastic chemotherapy drugs subcutaneously or intramuscularly to the patient.	1,620	$50	$82.4K
86235	The lab analyst performs an assay to evaluate the patient’s serum for each antibody to an extractable nuclear antigen, also called ENA. Types of ENA antibodies include anti ribonuclear protein,…	3,760	$20	$64K

Showing 1–10 of 75

Medicare: Competitive Analysis & Benchmarks

How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 75 CPT/HCPCS codes.

View: State1 / 2

Claims Volume vs. Tennessee Distribution

Raza Hashmi — 18 of 25 codes billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — Tennessee

Full comparison — all codes billed, vs. state median

75 rows

CPT/HCPCS Code	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
J0129	3	30	8,810	$30	$362.8K
J0717	1	20	50,400	$1	$263.1K
J3111	7	20	15,540	$10	$256.9K
J3262	1	10	44,440	$1	$249.7K
J1602	23	30	19,810	$10	$220.2K
Q5104	1	10	4,550	$30	$135.4K
J0897	8	240	2,940	$20	$85K
86235	2	10	360	$20	$27.6K
96413	10	240	150	$90	$18.9K
99214	69	11,370	120	$80	$16.6K

Showing 1–10 of 75

Related Providers

Other providers that share a Tax Identification Number (TIN) with Raza Hashmi, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Nikolaus King	TN	Acute Care Nurse Practitioner	$2.4M	$0
Ashley Hatchett	TN	Family Nurse Practitioner	$1.7M	$0
Mohamed Bashar Shala	TN	Interventional Cardiology Physician	$1M	$0
Randy Villanueva	TN	Internal Medicine Physician	$744.9K	$0
Maher Ghawji	TN	Endocrinology, Diabetes & Metabolism Physician	$721.7K	$0
Nidal Rahal	TN	Family Medicine Physician	$695.2K	$580
Kashif Latif	TN	Specialist	$693.1K	$0
George Rushing	TN	Internal Medicine Physician	$652.2K	$0
Mohammad Qureshi	TN	Specialist	$645.7K	$0
John Buttross	TN	Internal Medicine Physician	$610.5K	$0

Nearby Providers

Other providers in the same ZIP code as Raza Hashmi, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Byram Healthcare Centers, Inc.	TN	Durable Medical Equipment & Medical Supplies	$0	$44.3M
Campbell Clinic, PC	TN	Orthopaedic Surgery Physician	$0	$28M
The West Clinic P.C.	TN	Specialist	$0	$16M
Poplar Avenue Clinic PLLC	TN	Gynecologic Oncology Physician	$0	$9.7M
Diagnostic Ultrasound Consultants	TN	Diagnostic Radiology Physician	$0	$8.5M
Mid-south Imaging & Therapeutics, P.A.	TN	Diagnostic Radiology Physician	$0	$8.2M
David Portnoy	TN	Hematology & Oncology Physician	$6.5M	$0
Stephen Huddleston	TN	Retina Specialist (Ophthalmology) Physician	$5.7M	$0
Stern Cardiovascular Foundation, Inc	TN	Cardiovascular Disease Physician	$0	$4.7M
G I Diagnostic And Therapeutic Center LLC	TN	Endoscopy Clinic/Center	$4.2M	$8.6K

Raza Hashmi — Billing Profile & Reimbursement Data

Sign up for Raza Hashmi — Billing Profile & Reimbursement Data policy alerts

Raza Hashmi — Billing Profile & Reimbursement Data

Sign up for Raza Hashmi — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicare: Total Revenue Breakdown by CPT/HCPCS Code

Medicare: Complete Services Breakdown

Medicare: Competitive Analysis & Benchmarks

Related Providers

Nearby Providers

Frequently Asked Questions

References